Japan, Jan. 20 -- SIEMENS HEALTHCARE DIAGNOSTICS INC has got intellectual property rights for 'ANTI-NALOXONE AND ANTI-NALTREXONE MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF.' Other related details are as follows:
Application Number: JP,2024-010078
Category (FI): C12N1/21,C12P21/08,C12P21/02@C,C12N5/16,C12N5/10,C12N15/63@Z,C12N15/13,C12N15/06,100,C12N1/19,C12N1/15,C07K16/44
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Jan. 26, 2024
Publication Date: April 2, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
